An agonist of the adenosine A
CGS21680
YAP
adenosine A2A receptor
corneal epithelial wound healing
migration
proliferation
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
15 Jun 2024
15 Jun 2024
Historique:
revised:
17
11
2023
received:
04
07
2023
accepted:
29
11
2023
medline:
15
6
2024
pubmed:
15
6
2024
entrez:
15
6
2024
Statut:
aheadofprint
Résumé
The adenosine A A A A
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
The adenosine A
EXPERIMENTAL APPROACH
METHODS
A
KEY RESULTS
RESULTS
A
CONCLUSION AND IMPLICATIONS
CONCLUSIONS
A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Natural Science Foundation of China
ID : 31970948
Organisme : National Natural Science Foundation of China
ID : 82151308
Organisme : Major Project of Brain Science and Brain-like Intelligence Technology Research on the Sci-Tech Innovation 2030
ID : ZX-2021ZD0203404-XZ
Informations de copyright
© 2024 British Pharmacological Society.
Références
Agrahari, V., Mandal, A., Agrahari, V., Trinh, H. M., Joseph, M., Ray, A., Hadji, H., Mitra, R., Pal, D., & Mitra, A. K. (2016). A comprehensive insight on ocular pharmacokinetics. Drug Delivery and Translational Research, 6(6), 735–754. https://doi.org/10.1007/s13346-016-0339-2
Akowuah, P. K., De La Cruz, A., Smith, C. W., Rumbaut, R. E., & Burns, A. R. (2021). An epithelial abrasion model for studying corneal wound healing. Journal of Vision Experiments, (178), e63112. https://doi.org/10.3791/63112
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Abbracchio, M. P., Alexander, W., Al‐Hosaini, K., Bäck, M., Barnes, N. M., … Ye, R. D. (2021). The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors. British Journal of Pharmacology, 178(Suppl 1), S27–S156. https://doi.org/10.1111/bph.15538
Alexander, S. P. H., Roberts, R. E., Broughton, B. R. S., Sobey, C. G., George, C. H., Stanford, S. C., Cirino, G., Docherty, J. R., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., MacEwan, D. J., Mangum, J., Wonnacott, S., … Ahluwalia, A. (2018). Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology. British Journal of Pharmacology, 175(3), 407–411. https://doi.org/10.1111/bph.14112
Altavilla, D., Squadrito, F., Polito, F., Irrera, N., Calò, M., Lo Cascio, P., Galeano, M., La Cava, L., Minutoli, L., & Marini, H. (2011). Activation of adenosine A2A receptors restores the altered cell‐cycle machinery during impaired wound healing in genetically diabetic mice. Surgery, 149(2), 253–261. https://doi.org/10.1016/j.surg.2010.04.024
Boia, R., Elvas, F., Madeira, M. H., Aires, I. D., Rodrigues‐Neves, A. C., Tralhao, P., Szabó, E. C., Baqi, Y., Müller, C. E., Tomé, Â. R., Cunha, R. A., Ambrósio, A. F., & Santiago, A. R. (2017). Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death & Disease, 8(10), e3065. https://doi.org/10.1038/cddis.2017.451
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018). Pharmacology of adenosine receptors: The state of the art. Physiological Reviews, 98(3), 1591–1625. https://doi.org/10.1152/physrev.00049.2017
Borroto‐Escuela, D. O., Romero‐Fernandez, W., Tarakanov, A. O., Ciruela, F., Agnati, L. F., & Fuxe, K. (2011). On the existence of a possible A2A–D2–β‐arrestin2 complex: A2A agonist modulation of D2 agonist‐induced β‐arrestin2 recruitment. Journal of Molecular Biology, 406(5), 687–699. https://doi.org/10.1016/j.jmb.2011.01.022
Boucher, I., Rich, C., Lee, A., Marcincin, M., & Trinkaus‐Randall, V. (2010). The P2Y2 receptor mediates the epithelial injury response and cell migration. American Journal of Physiology. Cell Physiology, 299(2), C411–C421. https://doi.org/10.1152/ajpcell.00100.2009
Burgueno, J., Blake, D. J., Benson, M. A., Tinsley, C. L., Esapa, C. T., Canela, E. I., Penela, P., Mallol, J., Mayor, F. Jr., Lluis, C., Franco, R., & Ciruela, F. (2003). The adenosine A2A receptor interacts with the actin‐binding protein α‐actinin. The Journal of Biological Chemistry, 278(39), 37545–37552. https://doi.org/10.1074/jbc.M302809200
Chen, J. F., Eltzschig, H. K., & Fredholm, B. B. (2013). Adenosine receptors as drug targets—What are the challenges? Nature Reviews. Drug Discovery, 12(4), 265–286. https://doi.org/10.1038/nrd3955
Cho, Y. S., & Jiang, J. (2021). Hippo‐independent regulation of Yki/Yap/Taz: A non‐canonical view. Frontiers in Cell and Development Biology, 9, 658481. https://doi.org/10.3389/fcell.2021.658481
Curtis, M. J., Alexander, S. P. H., Cirino, G., George, C. H., Kendall, D. A., Insel, P. A., Izzo, A. A., Ji, Y., Panettieri, R. A., Patel, H. H., Sobey, C. G., Stanford, S. C., Stanley, P., Stefanska, B., Stephens, G. J., Teixeira, M. M., Vergnolle, N., & Ahluwalia, A. (2022). Planning experiments: Updated guidance on experimental design and analysis and their reporting III. British Journal of Pharmacology, 179(15), 3907–3913. https://doi.org/10.1111/bph.15868
Dey, A., Varelas, X., & Guan, K. L. (2020). Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nature Reviews. Drug Discovery, 19(7), 480–494. https://doi.org/10.1038/s41573-020-0070-z
Feoktistov, I., Biaggioni, I., & Cronstein, B. N. (2009). Adenosine receptors in wound healing, fibrosis and angiogenesis. Adenosine receptors in health and disease. Handbook of experimental pharmacology (193), 383–397. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-89615-9_13
Fozard, J. R., Ellis, K. M., Villela Dantas, M. F., Tigani, B., & Mazzoni, L. (2002). Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. European Journal of Pharmacology, 438(3), 183–188. https://doi.org/10.1016/s0014-2999(02)01305-5
Guerrero, A. (2018). A2A adenosine receptor agonists and their potential therapeutic applications. An update. Curr Med Chem, 25(30), 3597–3612. https://doi.org/10.2174/0929867325666180313110254
Hori, K., Sotozono, C., Hamuro, J., Yamasaki, K., Kimura, Y., Ozeki, M., Tabata, Y., & Kinoshita, S. (2007). Controlled‐release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. Journal of Controlled Release, 118(2), 169–176. https://doi.org/10.1016/j.jconrel.2006.12.011
Huang, L., Wu, D. D., Zhang, L., & Feng, L. Y. (2013). Modulation of A2a receptor antagonist on D2 receptor internalization and ERK phosphorylation. Acta Pharmacologica Sinica, 34(10), 1292–1300. https://doi.org/10.1038/aps.2013.87
Huang, P. C., Hsiao, Y. T., Kao, S. Y., Chen, C. F., Chen, Y. C., Chiang, C. W., Lee, C. F., Lu, J. C., Chern, Y., & Wang, C. T. (2014). Adenosine A2A receptor up‐regulates retinal wave frequency via starburst amacrine cells in the developing rat retina. PLoS ONE, 9(4), e95090. https://doi.org/10.1371/journal.pone.0095090
Ijzerman, A. P., Jacobson, K. A., Muller, C. E., Cronstein, B. N., & Cunha, R. A. (2022). International Union of Basic and Clinical Pharmacology. CXII: Adenosine receptors: A further update. Pharmacological Reviews, 74(2), 340–372. https://doi.org/10.1124/pharmrev.121.000445
Jacobson, K. A., Tosh, D. K., Jain, S., & Gao, Z. G. (2019). Historical and current adenosine receptor agonists in preclinical and clinical development. Frontiers in Cellular Neuroscience, 13, 124. https://doi.org/10.3389/fncel.2019.00124
Kamil, S., & Mohan, R. R. (2021). Corneal stromal wound healing: Major regulators and therapeutic targets. The Ocular Surface, 19, 290–306. https://doi.org/10.1016/j.jtos.2020.10.006
Khoa, N. D., Postow, M., Danielsson, J., & Cronstein, B. N. (2006). TNF‐α prevents desensitization of Gαs‐coupled receptors by regulating GRK2 association with the plasma membrane. Molecular Pharmacology, 69(4), 1311–1319. https://doi.org/10.1124/mol.105.016857
Kim, M., Kim, J. M., Cho, E. J., Sung, C. O., Kim, J., & Jang, S. J. (2023). β‐Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity. Genes Disease, 10(2), 348–351. https://doi.org/10.1016/j.gendis.2022.04.017
Klepeis, V. E., Weinger, I., Kaczmarek, E., & Trinkaus‐Randall, V. (2004). P2Y receptors play a critical role in epithelial cell communication and migration. Journal of Cellular Biochemistry, 93(6), 1115–1133. https://doi.org/10.1002/jcb.20258
Lee, H., Koh, B. H., Peri, L. E., Sanders, K. M., & Koh, S. D. (2014). Purinergic inhibitory regulation of murine detrusor muscles mediated by PDGFRα+ interstitial cells. The Journal of Physiology, 592(6), 1283–1293. https://doi.org/10.1113/jphysiol.2013.267989
Lee, M., Goraya, N., Kim, S., & Cho, S. H. (2018). Hippo‐yap signaling in ocular development and disease. Developmental Dynamics, 247(6), 794–806. https://doi.org/10.1002/dvdy.24628
Lilley, E., Stanford, S. C., Kendall, D. E., Alexander, S. P. H., Cirino, G., Docherty, J. R., George, C. H., Insel, P. A., Izzo, A. A., Ji, Y., Panettieri, R. A., Sobey, C. G., Stefanska, B., Stephens, G., Teixeira, M., & Ahluwalia, A. (2020). ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020. British Journal of Pharmacology, 177(16), 3611–3616. https://doi.org/10.1111/bph.15178
Lin, Y., Liu, Q., Li, L., Yang, R., Ye, J., Yang, S., Luo, G., Reinach, P. S., & Yan, D. (2022). Sirt1 regulates corneal epithelial migration by deacetylating cortactin. Investigative Ophthalmology & Visual Science, 63(12), 14. https://doi.org/10.1167/iovs.63.12.14
Liu, A. M., Xu, M. Z., Chen, J., Poon, R. T., & Luk, J. M. (2010). Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opinion on Therapeutic Targets, 14(8), 855–868. https://doi.org/10.1517/14728222.2010.499361
Liu, C. Y., & Kao, W. W. (2015). Corneal epithelial wound healing. Progress in Molecular Biology and Translational Science, 134, 61–71. https://doi.org/10.1016/bs.pmbts.2015.05.002
Liu, Z., Yan, S., Wang, J., Xu, Y., Wang, Y., Zhang, S., Xu, X., Yang, Q., Zeng, X., Zhou, Y., Gu, X., Lu, S., Fu, Z., Fulton, D. J., Weintraub, N. L., Caldwell, R. B., Zhang, W., Wu, C., Liu, X. L., … Huo, Y. (2017). Endothelial adenosine A2a receptor‐mediated glycolysis is essential for pathological retinal angiogenesis. Nature Communications, 8(1), 584. https://doi.org/10.1038/s41467-017-00551-2
Lopes, L. V., Halldner, L., Rebola, N., Johansson, B., Ledent, C., Chen, J. F., Fredholm, B. B., & Cunha, R. A. (2004). Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout mice. British Journal of Pharmacology, 141(6), 1006–1014. https://doi.org/10.1038/sj.bjp.0705692
Ma, L., Yang, F., Wu, X., Mao, C., Guo, L., Miao, T., Zang, S. K., Jiang, X., Shen, D. D., Wei, T., Zhou, H., Wei, Q., Li, S., Shu, Q., Feng, S., Jiang, C., Chu, B., Du, L., Sun, J. P., … Zhang, P. (2022). Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity. Proceedings of the National Academy of Sciences of the United States of America, 119(29), e2117054119. https://doi.org/10.1073/pnas.2117054119
Madeira, M. H., Boia, R., Elvas, F., Martins, T., Cunha, R. A., Ambrosio, A. F., & Santiago, A. R. (2016). Selective A2A receptor antagonist prevents microglia‐mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure‐induced transient ischemic injury. Translational Research, 169, 112–128. https://doi.org/10.1016/j.trsl.2015.11.005
Mayo, C., Ren, R., Rich, C., Stepp, M. A., & Trinkaus‐Randall, V. (2008). Regulation by P2X7: Epithelial migration and stromal organization in the cornea. Investigative Ophthalmology & Visual Science, 49(10), 4384–4391. https://doi.org/10.1167/iovs.08-1688
Mingote, S., Pereira, M., Farrar, A. M., McLaughlin, P. J., & Salamone, J. D. (2008). Systemic administration of the adenosine A2A agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake. Pharmacology, Biochemistry, and Behavior, 89(3), 345–351. https://doi.org/10.1016/j.pbb.2008.01.006
Minns, M. S., Teicher, G., Rich, C. B., & Trinkaus‐Randall, V. (2016). Purinoreceptor P2X7 regulation of Ca2+ mobilization and cytoskeletal rearrangement is required for corneal reepithelialization after injury. The American Journal of Pathology, 186(2), 285–296. https://doi.org/10.1016/j.ajpath.2015.10.006
Minns, M. S., & Trinkaus‐Randall, V. (2016). Purinergic signaling in corneal wound healing: A tale of 2 receptors. Journal of Ocular Pharmacology and Therapeutics, 32(8), 498–503. https://doi.org/10.1089/jop.2016.0009
Montesinos, M. C., Desai‐Merchant, A., & Cronstein, B. N. (2015). Promotion of wound healing by an agonist of adenosine A2A receptor is dependent on tissue plasminogen activator. Inflammation, 38(6), 2036–2041. https://doi.org/10.1007/s10753-015-0184-3
Montesinos, M. C., Gadangi, P., Longaker, M., Sung, J., Levine, J., Nilsen, D., Reibman, J., Li, M., Jiang, C. K., Hirschhorn, R., Recht, P. A., Ostad, E., Levin, R. I., & Cronstein, B. N. (1997). Wound healing is accelerated by agonists of adenosine A2 (Gαs‐linked) receptors. The Journal of Experimental Medicine, 186(9), 1615–1620. https://doi.org/10.1084/jem.186.9.1615
Nagaoka, K., Asaoka, N., Nagayasu, K., Shirakawa, H., & Kaneko, S. (2022). Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist‐induced dyskinesia via β‐arrestin signaling. Frontiers in Neuroscience, 16, 1082375. https://doi.org/10.3389/fnins.2022.1082375
Nguyen, K. D. Q., Vigers, M., Sefah, E., Seppala, S., Hoover, J. P., Schonenbach, N. S., Mertz, B., O'Malley, M. A., & Han, S. (2021). Homo‐oligomerization of the human adenosine A2A receptor is driven by the intrinsically disordered C‐terminus. eLife, 10, e66662. https://doi.org/10.7554/eLife.66662
Okada, S. F., Zhang, L., Kreda, S. M., Abdullah, L. H., Davis, C. W., Pickles, R. J., Lazarowski, E. R., & Boucher, R. C. (2011). Coupled nucleotide and mucin hypersecretion from goblet‐cell metaplastic human airway epithelium. American Journal of Respiratory Cell and Molecular Biology, 45(2), 253–260. https://doi.org/10.1165/rcmb.2010-0253OC
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., Garner, P., Holgate, S. T., Howells, D. W., Karp, N. A., Lazic, S. E., Lidster, K., CJ, M. C., Macleod, M., … Würbel, H. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. British Journal of Pharmacology, 177(16), 3617–3624. https://doi.org/10.1111/bph.15193
Shaikh, G., & Cronstein, B. (2016). Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis. Purinergic Signal, 12(2), 191–197. https://doi.org/10.1007/s11302-016-9498-3
Tan‐Allen, K. Y., Sun, X. C., & Bonanno, J. A. (2005). Characterization of adenosine receptors in bovine corneal endothelium. Experimental Eye Research, 80(5), 687–696. https://doi.org/10.1016/j.exer.2004.12.002
Tocci, P., Cianfrocca, R., Di Castro, V., Rosano, L., Sacconi, A., Donzelli, S., Bonfiglio, S., Bucci, G., Vizza, E., Ferrandina, G., Scambia, G., Tonon, G., Blandino, G., & Bagnato, A. (2019). β‐arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high‐grade serous ovarian cancer. Nature Communications, 10(1), 3196. https://doi.org/10.1038/s41467-019-11045-8
Tocci, P., Cianfrocca, R., Sestito, R., Rosanò, L., Di Castro, V., Blandino, G., & Bagnato, A. (2020). Endothelin‐1 axis fosters YAP‐induced chemotherapy escape in ovarian cancer. Cancer Letters, 492, 84–95. https://doi.org/10.1016/j.canlet.2020.08.026
Tran, G. B., Ding, J., Ye, B., Liu, M., Yu, Y., Zha, Y., … Ding, H. F. (2023). Caffeine supplementation and FOXM1 inhibition enhance the antitumor effect of statins in neuroblastoma. Cancer Research, 83(13), 2248–2261. https://doi.org/10.1158/0008-5472.Can-22-3450
Tsutsumi, O., Tsutsumi, A., & Oka, T. (1988). Epidermal growth factor‐like, corneal wound healing substance in mouse tears. The Journal of Clinical Investigation, 81(4), 1067–1071. https://doi.org/10.1172/jci113418
Victor‐Vega, C., Desai, A., Montesinos, M. C., & Cronstein, B. N. (2002). Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet‐derived growth factor (Becaplermin gel). Inflammation, 26(1), 19–24. https://doi.org/10.1023/a:1014417728325
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017). Targeting immunosuppressive adenosine in cancer. Nature Reviews. Cancer, 17(12), 709–724. https://doi.org/10.1038/nrc.2017.86
Wang, M., Li, P., Li, Z., da Silva, B. S., Zheng, W., Xiang, Z., He, Y., Xu, T., Cordeiro, C., Deng, L., Dai, Y., Ye, M., Lin, Z., Zhou, J., Zhou, X., Ye, F., Cunha, R. A., Chen, J., & Guo, W. (2023). Lateral septum adenosine A2A receptors control stress‐induced depressive‐like behaviors via signaling to the hypothalamus and habenula. Nature Communications, 14(1), 1880. https://doi.org/10.1038/s41467-023-37601-x
Weinger, I., Klepeis, V. E., & Trinkaus‐Randall, V. (2005). Tri‐nucleotide receptors play a critical role in epithelial cell wound repair. Purinergic Signal, 1(3), 281–292. https://doi.org/10.1007/s11302-005-8132-6
Yu, F. X., & Guan, K. L. (2013). The Hippo pathway: Regulators and regulations. Genes & Development, 27(4), 355–371. https://doi.org/10.1101/gad.210773.112
Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X. D., Mills, G. B., & Guan, K. L. (2012). Regulation of the Hippo‐YAP pathway by G‐protein‐coupled receptor signaling. Cell, 150(4), 780–791. https://doi.org/10.1016/j.cell.2012.06.037
Zhao, B., Li, L., Tumaneng, K., Wang, C. Y., & Guan, K. L. (2010). A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ‐TRCP. Genes & Development, 24(1), 72–85. https://doi.org/10.1101/gad.1843810
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., & Guan, K. L. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes & Development, 21(21), 2747–2761. https://doi.org/10.1101/gad.1602907
Zhou, R., Zhang, S., Gu, X., Ge, Y., Zhong, D., Zhou, Y., Tang, L., Liu, X. L., & Chen, J. F. (2018). Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy. Molecular Medicine, 24(1), 41. https://doi.org/10.1186/s10020-018-0038-1